Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase.

Suppr

超能文献

作者信息

Frye S V, Bramson H N, Hermann D J, Lee F W, Sinhababu A K, Tian G

机构信息

Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709, USA.

出版信息

Pharm Biotechnol. 1998;11:393-422. doi: 10.1007/0-306-47384-4_17.

DOI:10.1007/0-306-47384-4_17

PMID:9760689

Abstract

摘要

相似文献

Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase.

Pharm Biotechnol. 1998;11:393-422. doi: 10.1007/0-306-47384-4_17.

Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR.GG745的独特临床前特征，一种强效5α还原酶双重抑制剂。

J Pharmacol Exp Ther. 1997 Sep;282(3):1496-502.

Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors.

J Steroid Biochem Mol Biol. 1995 Sep;54(5-6):273-9. doi: 10.1016/0960-0760(95)00134-l.

Stable expression of the human 5alpha-reductase isoenzymes type I and type II in HEK293 cells to identify dual and selective inhibitors.人I型和II型5α-还原酶同工酶在HEK293细胞中的稳定表达以鉴定双重和选择性抑制剂。

J Enzyme Inhib. 2001 Jan;16(1):47-53. doi: 10.1080/14756360109162354.

The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.度他雄胺和非那雄胺抑制5α-还原酶对健康年轻男性骨矿物质密度、血清脂蛋白、血红蛋白、前列腺特异性抗原及性功能的影响

J Urol. 2008 Jun;179(6):2333-8. doi: 10.1016/j.juro.2008.01.145. Epub 2008 Apr 18.

A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.在不可逆5α-还原酶抑制剂GI198745和非那雄胺存在的情况下二氢睾酮周转的模型。

Clin Pharmacol Ther. 1998 Dec;64(6):636-47. doi: 10.1016/S0009-9236(98)90054-6.

Actions of 5alpha-reductase inhibitors on the epididymis.5α-还原酶抑制剂对附睾的作用。

Mol Cell Endocrinol. 2006 May 16;250(1-2):190-5. doi: 10.1016/j.mce.2005.12.044. Epub 2006 Feb 14.

Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat.5α-还原酶抑制剂对大鼠前列腺内雄激素的影响。

J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):381-5. doi: 10.1016/0960-0760(95)00083-c.

Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.新型1型5α-还原酶抑制剂MK-386单独及与非那雄胺联合应用对男性血清双氢睾酮浓度的影响。

J Clin Endocrinol Metab. 1996 Aug;81(8):2942-7. doi: 10.1210/jcem.81.8.8768856.

Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.人Ⅱ型类固醇5α还原酶的药物遗传学分析：非那雄胺与度他雄胺的比较

J Mol Endocrinol. 2005 Jun;34(3):617-23. doi: 10.1677/jme.1.01725.

引用本文的文献

The post-finasteride syndrome: possible etiological mechanisms and symptoms.非那雄胺后综合征：可能的病因机制及症状

Int J Impot Res. 2023 Sep 11. doi: 10.1038/s41443-023-00759-5.

Post-finasteride syndrome: An emerging clinical problem.非那雄胺后综合征：一个新出现的临床问题。

Neurobiol Stress. 2019 Dec 26;12:100209. doi: 10.1016/j.ynstr.2019.100209. eCollection 2020 May.

Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?前列腺素 E1 联合多虑平治疗糖尿病性勃起功能障碍的临床观察

Endocrine. 2018 Aug;61(2):180-193. doi: 10.1007/s12020-018-1593-5. Epub 2018 Apr 19.

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.5-α还原酶抑制剂在良性前列腺增生治疗中的应用。

Asian J Urol. 2018 Jan;5(1):28-32. doi: 10.1016/j.ajur.2017.11.005. Epub 2017 Nov 26.

Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?5α-还原酶抑制剂的不良反应：我们知道什么、不知道什么以及需要知道什么？

Rev Endocr Metab Disord. 2015 Sep;16(3):177-98. doi: 10.1007/s11154-015-9319-y.

Testosterone reduces knee passive range of motion and expression of relaxin receptor isoforms via 5α-dihydrotestosterone and androgen receptor binding.睾酮通过5α-二氢睾酮和雄激素受体结合降低膝关节被动活动范围和松弛素受体亚型的表达。

Int J Mol Sci. 2014 Mar 17;15(3):4619-34. doi: 10.3390/ijms15034619.

A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance.多尺度、机制驱动的 5α-还原酶抑制对前列腺维持作用的动态模型。

PLoS One. 2012;7(9):e44359. doi: 10.1371/journal.pone.0044359. Epub 2012 Sep 6.

Dutasteride.度他雄胺

Drugs Aging. 2003;20(12):905-16; discussion 917-8. doi: 10.2165/00002512-200320120-00005.

Mass spectral fragmentation reactions of a therapeutic 4-azasteroid and related compounds.

J Am Soc Mass Spectrom. 2001 Apr;12(4):385-98. doi: 10.1016/S1044-0305(01)00203-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验